FTSE All-Share
4.566,12
PKT
+69,55
PKT
+1,55
%
Werbung
Analysen zu FTSE All-Share-Werten
Datum | Rating | Analyst | |
---|---|---|---|
28.03.24 | AstraZeneca Sell | Deutsche Bank AG | |
28.03.24 | GSK Underweight | JP Morgan Chase & Co. | |
27.03.24 | Rio Tinto Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
27.03.24 | Vodafone Group Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
27.03.24 | HSBC Equal Weight | Barclays Capital | |
25.03.24 | Rio Tinto Buy | Deutsche Bank AG | |
25.03.24 | AstraZeneca Sell | UBS AG | |
25.03.24 | HSBC Neutral | UBS AG | |
25.03.24 | Unilever Sell | UBS AG | |
20.03.24 | GSK Buy | Jefferies & Company Inc. | |
19.03.24 | Unilever Underperform | Jefferies & Company Inc. | |
19.03.24 | Unilever Underweight | JP Morgan Chase & Co. | |
19.03.24 | Unilever Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
19.03.24 | Unilever Sell | UBS AG | |
19.03.24 | Unilever Overweight | Barclays Capital | |
19.03.24 | Vodafone Group Equal Weight | Barclays Capital | |
19.03.24 | Unilever Market-Perform | Bernstein Research | |
19.03.24 | Diageo Outperform | Bernstein Research | |
19.03.24 | AstraZeneca Sell | UBS AG | |
19.03.24 | Unilever Sector Perform | RBC Capital Markets | |
19.03.24 | GSK Buy | UBS AG | |
18.03.24 | Shell (ex Royal Dutch Shell) Overweight | Barclays Capital | |
18.03.24 | GSK Underweight | JP Morgan Chase & Co. | |
18.03.24 | BAT Neutral | Goldman Sachs Group Inc. | |
15.03.24 | Vodafone Group Buy | UBS AG | |
15.03.24 | AstraZeneca Sell | Deutsche Bank AG | |
15.03.24 | Glencore Outperform | RBC Capital Markets | |
15.03.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
14.03.24 | Shell (ex Royal Dutch Shell) Neutral | UBS AG | |
14.03.24 | BP Buy | UBS AG | |
14.03.24 | BAT Neutral | UBS AG | |
13.03.24 | Glencore Buy | Deutsche Bank AG | |
12.03.24 | BAT Buy | Jefferies & Company Inc. | |
12.03.24 | BAT Neutral | UBS AG | |
11.03.24 | BAT Buy | Jefferies & Company Inc. | |
11.03.24 | Unilever Market-Perform | Bernstein Research | |
07.03.24 | GSK Underweight | JP Morgan Chase & Co. | |
07.03.24 | GSK Buy | UBS AG | |
05.03.24 | BP Buy | UBS AG | |
04.03.24 | BP Buy | Jefferies & Company Inc. |